Clinical Study of MAK Immune Cells in the Treatment of PHC

计划入组 12 人 · 首次发布于 2022 年 2 月 16 日

Evaluation of the Safety and Usability of the MAK Exoskeleton in Patients With Stroke

计划入组 6 人 · 首次发布于 2021 年 4 月 8 日

Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

计划入组 138 人 · 首次发布于 2001 年 2 月 5 日

MAK-11049

I-MAB Biopharma Co., Ltd.

China

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

Patent Extensions Drive $200 Billion in Excess U.S. Drug Spending, I-MAK Analysis Reveals

FDA Commissioner Assures Drug Review Timelines Will Be Met Despite Mass Layoffs

Oregon Advocates Push for 2027 Legislation Mandating Insurance Coverage of Biomarker Testing